Centiva Capital, LP Vertex Pharmaceuticals Inc Call Options Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $39,281 - $48,553	-100 Reduced 9.09%	1,000 $468,000
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $3.26 Million - $3.57 Million	-8,000 Reduced 87.91%	1,100 $459,000
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $34,300 - $41,068	100 Added 1.11%	9,100 $3.7 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $845,450 - $906,150	2,500 Added 38.46%	9,000 $3.13 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $3.97 Million - $4.52 Million	-14,000 Reduced 68.29%	6,500 $2.05 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $1.43 Million - $1.61 Million	-5,000 Reduced 19.61%	20,500 $5.92 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $3.29 Million - $3.67 Million	12,000 Added 88.89%	25,500 $7.38 Million
Q2 2022 Aug 17, 2022	SELL	$234.96 - $292.55 $140,976 - $175,530	-600 Reduced 4.26%	13,500 $3.8 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $2.01 Million - $2.37 Million	9,100 Added 182.0%	14,100 $3.68 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $885,050 - $1.12 Million	5,000 New	5,000 $1.1 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $906,949 - $1.01 Million	-5,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $168,741 - $198,990	900 Added 21.95%	5,000 $1.01 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $766,632 - $1.01 Million	-3,400 Reduced 45.33%	4,100 $1.19 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $1.2 Million - $1.49 Million	6,000 Added 400.0%	7,500 $1.79 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $245,594 - $292,050	1,500 New	1,500 $276,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.61 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.33 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.06 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account